EDU experiments confirmed that tRF‐1‐Ser knockdown weakened the proliferative ability of breast cancer cells, whereas proliferation was restored and even enhanced upon tRF‐1‐Ser reintroduction (Figure 3C). This evidence concerns the gene TERF1 and breast carcinoma.